These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 21212920

  • 1. Knowledge, attitude, and practice of Iranian adolescent girls towards 3-4-methylenedioxymethamphetamine.
    Rahnavard Z, Eybpoosh S, Akhondzadeh S.
    Saudi Med J; 2011 Jan; 32(1):66-70. PubMed ID: 21212920
    [Abstract] [Full Text] [Related]

  • 2. Attitude towards and use of ecstasy in medical university interns' based on HBM.
    Baghianimoghadam MH, Mazloomy Mahmoodabad SS, Mohammadi S, Baghianimoghadam B.
    J Prev Med Hyg; 2009 Dec; 50(4):241-5. PubMed ID: 20812521
    [Abstract] [Full Text] [Related]

  • 3. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.
    Farah R, Farah R.
    Pediatr Emerg Care; 2008 Sep; 24(9):615-7. PubMed ID: 18797371
    [Abstract] [Full Text] [Related]

  • 4. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS.
    Biol Psychiatry; 1996 May 01; 39(9):819-20. PubMed ID: 8731525
    [No Abstract] [Full Text] [Related]

  • 5. Ecstasy related periodontitis and mucosal ulceration -- a case report.
    Brazier WJ, Dhariwal DK, Patton DW, Bishop K.
    Br Dent J; 2003 Feb 22; 194(4):197-9. PubMed ID: 12627194
    [Abstract] [Full Text] [Related]

  • 6. Iranian school teachers: knowledge and attitude toward ecstasy.
    Dabiran S, Khosravi S, Hatmi ZN, Sheikhvatan M.
    Int J Adolesc Med Health; 2009 Feb 22; 21(2):175-8. PubMed ID: 19702196
    [Abstract] [Full Text] [Related]

  • 7. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA, Rosner MH.
    Clin J Am Soc Nephrol; 2008 Nov 22; 3(6):1852-60. PubMed ID: 18684895
    [Abstract] [Full Text] [Related]

  • 8. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott K, Redman J.
    Neurosci Biobehav Rev; 2007 Nov 22; 31(3):327-47. PubMed ID: 17109962
    [Abstract] [Full Text] [Related]

  • 9. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN.
    Exp Clin Psychopharmacol; 2005 May 22; 13(2):137-45. PubMed ID: 15943546
    [Abstract] [Full Text] [Related]

  • 10. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    Patel MM, Belson MG, Longwater AB, Olson KR, Miller MA.
    J Emerg Med; 2005 Nov 22; 29(4):451-4. PubMed ID: 16243206
    [Abstract] [Full Text] [Related]

  • 11. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective.
    Parrott AC, Marsden CA.
    J Psychopharmacol; 2006 Mar 22; 20(2):143-6. PubMed ID: 16510473
    [No Abstract] [Full Text] [Related]

  • 12. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
    Cance JD, Ashley OS, Penne MA.
    J Adolesc Health; 2005 Nov 22; 37(5):409. PubMed ID: 16227128
    [Abstract] [Full Text] [Related]

  • 13. Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged exercise.
    Seymour HR, Gilman D, Quin JD.
    Diabet Med; 1996 Oct 22; 13(10):908-9. PubMed ID: 8911787
    [Abstract] [Full Text] [Related]

  • 14. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
    De Letter EA, Bouche MP, Van Bocxlaer JF, Lambert WE, Piette MH.
    Forensic Sci Int; 2004 May 10; 141(2-3):85-90. PubMed ID: 15062945
    [Abstract] [Full Text] [Related]

  • 15. [Psychological aspects of MDMA (ecstasy) users].
    Varescon I.
    Ann Med Interne (Paris); 2003 Nov 10; 154 Spec No 2():S81-5. PubMed ID: 14760230
    [Abstract] [Full Text] [Related]

  • 16. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul 10; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 17. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
    Raviña P, Quiroga JM, Raviña T.
    Int J Cardiol; 2004 Feb 10; 93(2-3):307-8. PubMed ID: 14975567
    [Abstract] [Full Text] [Related]

  • 18. Cognitive determinants of MDMA use among college students in Southern Taiwan.
    Yu RL, Ko HC.
    Addict Behav; 2006 Dec 10; 31(12):2199-211. PubMed ID: 16581197
    [Abstract] [Full Text] [Related]

  • 19. [Studies on the identification of psychotropic substances (VII). Preparation and various analytical data of standard references of some hallucinogens, 3,4-methylenedioxyamphetamine (MDA), 3,4- methylenedioxymethamphetamine (MDMA) and 5-methoxy-3,4- methylenedioxyamphetamine (MMDA)].
    Shimamine M, Takahashi K, Nakahara Y.
    Eisei Shikenjo Hokoku; 1990 Dec 10; (108):118-25. PubMed ID: 1364339
    [Abstract] [Full Text] [Related]

  • 20. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM, Appel JB.
    J Pharmacol Exp Ther; 1988 Sep 10; 246(3):866-70. PubMed ID: 2901488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.